Surgical Science Sweden AB (publ)
SUSRF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $5 | $7 | $6 | $8 |
| - Cash | $1 | $1 | $1 | $1 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $4 | $7 | $6 | $7 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 26% | -16.6% | -0.3% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 64.6% | 65.2% | 68.8% | 67.6% |
| EBITDA | $0 | -$0 | $0 | $0 |
| % Margin | 10.3% | -10.7% | 9.5% | 15.6% |
| Net Income | $0 | -$0 | $0 | $0 |
| % Margin | 7.7% | -9.6% | 13.3% | 14.4% |
| EPS Diluted | 0.4 | -0.39 | 0.65 | 0.71 |
| % Growth | 202.6% | -160% | -8.5% | – |
| Operating Cash Flow | -$0 | $0 | -$0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | $0 | -$0 | $0 |